Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions.
Data(s) |
2008
|
---|---|
Identificador |
http://serval.unil.ch/?id=serval:BIB_F375ACB8D8FD isbn:1774-024X pmid:19110780 |
Idioma(s) |
en |
Fonte |
EuroIntervention, vol. 4, no. 2, pp. 183-186 |
Palavras-Chave | #Angioplasty, Transluminal, Percutaneous Coronary; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Factors; Thrombosis |
Tipo |
info:eu-repo/semantics/review article |